These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 12005253

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of malignant features in oligodendroglial tumors.
    Saito A, Nakazato Y.
    Clin Neuropathol; 1999; 18(2):61-73. PubMed ID: 10192700
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 cases.
    Jentoft M, Giannini C, Rossi S, Mota R, Jenkins RB, Rodriguez FJ.
    Am J Surg Pathol; 2011 Jun; 35(6):845-52. PubMed ID: 21552114
    [Abstract] [Full Text] [Related]

  • 5. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
    Majumdar K, Radotra BD, Vasishta RK, Pathak A.
    Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
    [Abstract] [Full Text] [Related]

  • 6. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A, Ralte AM, Sharma MC, Singh VP, Mahapatra AK, Mehta VS, Sarkar C.
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [Abstract] [Full Text] [Related]

  • 7. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O, Demirhan B, Altinörs N.
    Clin Neuropathol; 2005 Jun; 24(5):219-24. PubMed ID: 16167545
    [Abstract] [Full Text] [Related]

  • 8. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.
    Kirla RM, Haapasalo HK, Kalimo H, Salminen EK.
    Cancer; 2003 Feb 01; 97(3):644-8. PubMed ID: 12548606
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular control of the cell cycle in cancer: biological and clinical aspects.
    Møller MB.
    Dan Med Bull; 2003 May 01; 50(2):118-38. PubMed ID: 12812137
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
    Prayson RA, Mohan DS, Song P, Suh JH.
    Ann Diagn Pathol; 2000 Aug 01; 4(4):218-27. PubMed ID: 10982299
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P, Saito T, Hama S, Arifin MT, Kajiwara Y, Yamasaki F, Hidaka T, Sugiyama K, Kurisu K.
    Cancer; 2007 Mar 01; 109(5):949-56. PubMed ID: 17262828
    [Abstract] [Full Text] [Related]

  • 20. MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes.
    Jenkinson MD, Smith TS, Joyce K, Fildes D, du Plessis DG, Warnke PC, Walker C.
    Neurology; 2005 Jun 28; 64(12):2085-9. PubMed ID: 15985578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.